CID 25102847

Cabozantinib

Structural Information

Molecular Formula
C28H24FN3O5
SMILES
COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F
InChI
InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)
InChIKey
ONIQOQHATWINJY-UHFFFAOYSA-N
Compound name
1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

890
References

25434
Patents

501.17 Da
Monoisotopic Mass

5.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 502.17728 215.0
[M+Na]+ 524.15922 222.1
[M-H]- 500.16272 225.6
[M+NH4]+ 519.20382 217.3
[M+K]+ 540.13316 217.5
[M+H-H2O]+ 484.16726 203.3
[M+HCOO]- 546.16820 234.3
[M+CH3COO]- 560.18385 246.6
[M+Na-2H]- 522.14467 217.9
[M]+ 501.16945 220.4
[M]- 501.17055 220.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe